Actxa, a Singapore-based preventive health technology company, recently announced significant enhancements to its proprietary BGEM technology, the world's first clinically backed, non-invasive, AI-driven blood glucose evaluation and monitoring technology. The advancements strengthen BGEM's ability to deliver medical-grade glucose insights through everyday wearables.
One key innovation is BGEM Glucose Range, a clinically backed, medical-grade technology that estimates blood glucose levels within a numeric range using a quick, one-minute measurement. Developed using data collected through clinical studies, BGEM Glucose Range offers pain-free and meaningful glucose insights anytime, throughout the day, it provides a cost-effective and convenient approach, making glucose monitoring accessible and sustainable.
BGEM Glucose Range: Medical-Grade, Non-Invasive Glucose Insight
BGEM Glucose Range represents a major advancement in non-invasive glucose evaluation. Using data from clinical studies, the technology estimates glucose levels within a dynamic range to enable convenient metabolic monitoring throughout the day.
Designed for wearable integration, BGEM Glucose Range delivers a cost-effective alternative to traditional glucose monitoring methods. BGEM Glucose Range combines wearable PPG sensors and AI-driven analysis of digital biomarkers to estimate blood glucose results.
Everyday Glucose Awareness on the Core Smart Ring
In addition, the Core Smart Ring, Actxa's first smart ring under the Core range, is integrated with the AI Glucose Scan feature, powered by BGEM Glucose Status technology, to help users take better control of their metabolic health. The feature enables users to check their glucose status and receive a Normal or Elevated result linked to daily habits.
Developed using clinically collected data, AI Glucose Scan interprets
Photoplethysmography (PPG) signals from the Core Smart Ring to provide simple, everyday glucose awareness. Paired with lifestyle and wellness guidance, the Core Smart Ring's AI Glucose Scan supports healthier decision-making and metabolic awareness.
Driving the Future of Non-Invasive Glucose Monitoring
"Glucose health is becoming a defining challenge for global preventive health, yet most monitoring solutions remain invasive, costly or difficult to sustain," said Marcus Soo, Chief Executive Officer of Actxa.
"We want to make health insights simple, personal, and actionable. Actxa is empowering individuals and partners to integrate preventative health and glucose awareness into everyday life.
